After axing its lead obesity asset…
After axing its lead obesity asset last year, BioAge Labs [...]
After axing its lead obesity asset last year, BioAge Labs [...]
BeOne Medicines has entered the BCL-2 arena, securing an FDA [...]
As President Trump lands in Beijing, one major industry is [...]
Lexicon CEO Michael Exton told Fierce how he set the [...]
Fosun Pharma has paid $60 million for an option on [...]
Valneva is planning to shrink its headcount by up to [...]
Shortly after locking down its $4.8 billion deal for rare [...]
Kyverna Therapeutics has officially started a rolling submission to the [...]
The new strategy also holds promise for lung and colon [...]
Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending [...]